TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 119 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2015. The put-call ratio across all filers is 4.19 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $487,000 | +7.0% | 4,179 | -3.4% | 0.02% | -5.3% |
| Q4 2016 | $455,000 | -78.5% | 4,326 | -77.4% | 0.02% | -78.4% |
| Q3 2016 | $2,112,000 | -4.2% | 19,107 | +26.2% | 0.09% | 0.0% |
| Q2 2016 | $2,204,000 | +135.0% | 15,136 | +149.4% | 0.09% | +137.8% |
| Q4 2015 | $938,000 | -17.8% | 6,068 | -23.6% | 0.04% | -9.8% |
| Q2 2015 | $1,141,000 | -18.0% | 7,943 | -19.5% | 0.04% | -18.0% |
| Q1 2015 | $1,392,000 | – | 9,872 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |